Insulin Like Growth Factor Beta1 (ILGF beta1) ELISA Kit for Human

Intended Uses: This IGF-B1 ELISA kit is a 1.5 hour solid-phase ELISA designed for the quantitative determination of Human IGF-B1. This ELISA kit for research use only!

Principle of the Assay: IGF-B1 ELISA kit applies the competitive enzyme immunoassay technique utilizing a monoclonal anti-IGF-B1 antibody and an IGF-B1 -HRP conjugate. The assay sample and buffer are incubated together with IGF-B1 -HRP conjugate in pre-coated plate for one hour. After the incubation period, the wells are decanted and washed five times. The wells are then incubated with a substrate for HRP enzyme. The product of the enzyme-substrate reaction forms a blue colored complex. Finally, a stop solution is added to stop the reaction, which will then turn the solution yellow. The intensity of color is measured spectrophotometrically at 450nm in a microplate reader. The intensity of the color is inversely proportional to the IGF-B1 concentration since IGF-B1 from samples and IGF-B1 -HRP conjugate compete for the anti-IGF-B1 antibody binding site. Since the number of sites is limited, as more sites are occupied by IGF-B1 from the sample, fewer sites are left to bind IGF-B1 -HRP conjugate. A standard curve is plotted relating the intensity of the color (O.D.) to the concentration of standards. The IGF-B1 concentration in each sample is interpolated from this standard curve.

Small volumes of ILGF beta1 elisa kit vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS730999 is a ready-to-use microwell, strip plate ELISA (enzyme-linked immunosorbent assay) Kit for analyzing the presence of the Insulin like Growth Factor beta1 (ILGF beta1) ELISA Kit target analytes in biological samples. The concentration gradients of the kit standards or positive controls render a theoretical kit detection range in biological research samples containing ILGF beta1. The ELISA analytical biochemical technique of the MBS730999 kit is based on ILGF beta1 antibody-ILGF beta1 antigen interactions (immunosorbency) and an HRP colorimetric detection system to detect ILGF beta1 antigen targets in samples. The ELISA Kit is designed to detect native, not recombinant, ILGF beta1. Appropriate sample types may include undiluted body fluids and/or tissue homogenates, secretions. Quality control assays assessing reproducibility identified the intra-assay CV (%) and inter-assay CV(%).